Shionogi

Akili hands off east Asia sales, clinical development, marketing of digital therapeutic to Japanese pharma
By Dave Muoio | 04:38 pm | March 07, 2019
Of note, the deal specifies that Akili will still control the rollout and support of its video game-like therapy through a yet-to-be-seen digital distribution platform.